Complement Factor H Polymorphism and Age-Related Macular Degeneration
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is a common, late-onset, and complex trait with multiple risk factors. Concentrating on a region harboring a locus for AMD on 1q25-31, the ARMD1 locus, we tested single-nucleotide polymorphisms for association with AMD in two independent case-control populations. Significant association ( P = 4.95 × 10 -10 ) was identified within the regulation of complement activation locus and was centered over a tyrosine-402 → histidine-402 protein polymorphism in the gene encoding complement factor H. Possession of at least one histidine at amino acid position 402 increased the risk of AMD 2.7-fold and may account for 50% of the attributable risk of AMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A major AMD-associated SNP is the Y402H (tyrosine to histidine substitution at amino acid 402) variant of complement factor H (CFH) (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“These SNPs have been reported to be major genetic factors for developing AMD in Caucasians (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Tuo et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“Complement activation playing a major role in AMD pathogenesis is yet another source of inflammation [107-110].”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [108]
In the citing paper
“Polymorphisms in human complement regulatory factor H (CFH) predispose individuals to AMD [35, 46, 59]”
From Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain (2022) · cites this paper as [35]
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [4]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Score Tests for Association between Traits and Haplotypes when Linkage Phase Is Ambiguous
Schaid, D. J., Rowland, C. M., Tines, D. E., Jacobson, R. M., & Poland, G. A. (2002) · The American Journal of Human Genetics · doi:10.1086/338688 · Cited by 1,783
The Five-year Incidence and Progression of Age-related Maculopathy
Klein, R., Klein, B. E. K., Jensen, S. C., & Meuer, S. M. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30368-6 · Cited by 1,135
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
The epidemiology of age-related macular degeneration
Klein, R., Peto, T., Bird, A., & Vannewkirk, M. R. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.069 · Cited by 932
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
Molecular Biology and Chemistry of the Alternative Pathway of Complement
Müller-Eberhard, H. J., & Schreiber, R. D. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60042-5 · Cited by 408
Seddon, J. M. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.6.785 · Cited by 398
Keenan, T. D., & Chew, E. Y. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2210 · Cited by 377
Research works printed but not linked: 1
- M. H. Wener, P. R. Daum, G. M. McQuillan, J. Rheumatol.27, 2351 (2000).
Cited by
Items 801–900 of 1,021
Complement Factor H Polymorphism p.Tyr402His and Cuticular Drusen
Grassi, M. A., Folk, J. C., Scheetz, T. E., Taylor, C. M., Sheffield, V. C., & Stone, E. M. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.1.93 · Cited by 61
“01) (Table 1), which corresponds well with prior studies where the reported frequency ranged from approximately 46% to 59%.(18-21) CT CC TT”
BackgroundResultJoint effects of smoking history and APOE genotypes in age-related macular degeneration.
Schmidt, S., Haines, J. L., Postel, E. A., Agarwal, A., Kwan, S. Y., Gilbert, J. R., Pericak‐Vance, M. A., & Scott, W. K. (2005) · PubMed · Cited by 59
Genetic markers and biomarkers for age-related macular degeneration
Ross, R. J., Verma, V., Rosenberg, K. I., Chan, C.-C., & Tuo, J. (2007) · Expert Review of Ophthalmology · doi:10.1586/17469899.2.3.443 · Cited by 54
Inflammation in the pathogenesis of age-related macular degeneration
Kanda, A., Abecasis, G., & Swaroop, A. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.131581 · Cited by 55
Feng, X., Xiao, J., Longville, B., Tan, A. X. J., Wu, X. N., Cooper, M. N., McAllister, I. L., Isaacs, T., Palmer, L. J., & Constable, I. J. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.03.011 · Cited by 54
Chen, H., Yu, K.-D., & Xu, G.-Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042464 · Cited by 51
“[3,4,5] Variant rs1061170 (T1277C, Y402H) in the CFH gene located in the heparin and CRP-binding domain may cause complement dysregulation and lead to the pathogenesis of AMD.”
Genomic aspects of age-related macular degeneration
Horie‐Inoue, K., & Inoue, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.013 · Cited by 60
Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes
Seddon, J. M., Reynolds, R. C., Yu, Y., & ROSNER, B. A. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.2578 · Cited by 58
“81 CC 755 (93) 1760 (84) 257 (87) 595 (87) CT/TT 54 (7) 345 (16) 37 (13) 90 (13) C3 rs2230199 (R102G) .”
Zinc Supplementation Inhibits Complement Activation in Age-Related Macular Degeneration
Smailhodzic, D., van Asten, F., Blom, A. M., Mohlin, F. C., den Hollander, A. I., van de Ven, J. P. H., van Huet, R. A. C., Groenewoud, J. M. M., Tian, Y., Berendschot, T. T. J. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112682 · Cited by 53
“Moreover, the discovery of a strong association between AMD and genetic variants in CFH gene, a major inhibitor of the alternative pathway, provided a second line of evidence in support of the inflammation model [19–22].”
Complement in glomerular injury
Berger, S. P., & Daha, M. R. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0090-3 · Cited by 54
“The finding of a close association of AMD with factor H mutations suggests that complement is also involved in the pathogenesis of this visually disabling disease [51–54].”
BackgroundGarland, D. L., Fernandez-Godino, R., Kaur, I., Speicher, K. D., Harnly, J. M., Lambris, J. D., Speicher, D. W., & Pierce, E. A. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt395 · Cited by 53
Age-related macular degeneration: genetic and clinical findings
Kokotas, H., Grigoriadou, M., & Petersen, M. B. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.091 · Cited by 64
Discovery of rare variants for complex phenotypes
Kosmicki, J. A., Churchhouse, C. L., Rivas, M. A., & Neale, B. M. (2016) · Human Genetics · doi:10.1007/s00439-016-1679-1 · Cited by 61
Wagner, E. K., Raychaudhuri, S., Villalonga, M. B., Java, A., Triebwasser, M. P., Daly, M. J., Atkinson, J. P., & Seddon, J. M. (2016) · Scientific Reports · doi:10.1038/srep31531 · Cited by 53
Parmar, V. M., Parmar, T., Arai, E., Perusek, L., & Maeda, A. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.01.014 · Cited by 54
“Additionally, after identification that CFH Y402H variant is associated with AMD in 2005, complement regulatory protein is considered as a major risk factor for developing AMD (Klein et al., 2005, Edwards et al., 2005, Haines et al., 2005, Hageman et al., 2005, Zareparsi et al., 2005).”
BackgroundMatrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
García‐Onrubia, L., Valentín-Bravo, F. J., Coco, R. M., González‐Sarmiento, R., Jimeno, J. C. P., Usategui‐Martín, R., & Pastor‐Idoate, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165934 · Cited by 61
Woo, S. J., Ahn, J., Morrison, M. A., Ahn, S. Y., Lee, J., Kim, K. W., DeAngelis, M. M., & Park, K. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132771 · Cited by 60
Lettre, G., Butler, J. L., Ardlie, K., & Hirschhorn, J. N. (2007) · Human Genetics · doi:10.1007/s00439-007-0385-4 · Cited by 58
“…in complex trait genetics suggest that many complex human diseases will be explained in part by genetic variants in novel and often unexpected genes (Amundadottir et al. 2006; Edwards et al. 2005; Freedman et al. 2006; Grant et al. 2006; Haines et al. 2005; Klein et al. 2005; Sladek et al. 2007).”
BackgroundEconomopoulou, M., Hammer, J., Wang, F., Fariss, R., Maminishkis, A., & Miller, S. S. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2129 · Cited by 54
Zee, R. Y. L., Diehl, K. A., & Ridker, P. M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.09.009 · Cited by 55
CHANG, M. A., Bressler, S. B., Muñoz, B. E., & West, S. K. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1584 · Cited by 62
Case-control studies in the genomic era: a clinician's guide
Healy, D. G. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70524-5 · Cited by 63
Age‐related macular degeneration: A disease of extracellular complement amplification
de Jong, S., Tang, J., & Clark, S. J. (2022) · Immunological Reviews · doi:10.1111/imr.13145 · Cited by 63
Ocular immune privilege and retinal pigment epithelial cells
Du, Y., & Yan, B. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiac016 · Cited by 59
Polyanion-Induced Self-Association of Complement Factor H
Pangburn, M. K., Rawal, N., Cortés, C., Alam, M. N., Ferreira, V. P., & Atkinson, M. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.2.1061 · Cited by 53
Kelly, U., Yu, L., Kumar, P., Ding, J.-D., Jiang, H., Hageman, G. S., Arshavsky, V. Y., Frank, M. M., Hauser, M. A., & Bowes Rickman, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903596 · Cited by 53
Association of TCF4 Gene Polymorphisms with Fuchs' Corneal Dystrophy in the Chinese
Thalamuthu, A., Khor, C. C., Venkataraman, D., Koh, L. W., Tan, D. T. H., Aung, T., Mehta, J. S., & Vithana, E. N. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7568 · Cited by 58
A 32 kb Critical Region Excluding Y402H in CFH Mediates Risk for Age-Related Macular Degeneration
Sivakumaran, T. A., Igo, R. P., Kidd, J. M., Itsara, A., Kopplin, L. J., Chen, W., Hagstrom, S. A., Peachey, N. S., Francis, P. J., Klein, M. L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025598 · Cited by 56
“Our clinical datasets include 293 individuals from 34 families participating in Familial Age-related Maculopathy Study (FARMS), 600 cases and controls (400 cases and 200 controls) participating in the Age-related Eye disease study (AREDS), a Michigan-Penn-Mayo (MPM) Panel containing of 2157 cases and 1150 controls, a…”
BackgroundInfluentialSelf-citationChen, Y., Hu, Y., Moiseyev, G., Zhou, K. K., Chen, D., & Ma, J.-X. (2009) · Microvascular Research · doi:10.1016/j.mvr.2009.02.005 · Cited by 46
A Rat Model for Choroidal Neovascularization Using Subretinal Lipid Hydroperoxide Injection
Baba, T., Bhutto, I. A., Merges, C. A., Grebe, R. R., Emmert, D. G., McLeod, D. S., Armstrong, D., & Lutty, G. A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090989 · Cited by 53
Lü, F., Zhao, P., Fan, Y., Tang, S., Hu, J., Liu, X., Yang, X. Q., Chen, Y., Li, T., Lei, C., et al. (2010) · PubMed Central · doi:10.3390/molecules16010001 · Cited by 54
Models of retinal diseases and their applicability in drug discovery
Malek, G., Busik, J. V., Grant, M. B., & Choudhary, M. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1430136 · Cited by 55
Singh, M., & Tyagi, S. C. (2018) · International Journal of Ophthalmology · doi:10.18240/ijo.2018.01.20 · Cited by 67
Cipriani, V., Tierney, A. L., Griffiths, J. R., Zuber, V., Sergouniotis, P. I., Yates, J. R. W., Moore, A. T., Bishop, P. N., Clark, S. J., & Unwin, R. D. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.05.015 · Cited by 56
Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option
Qin, S., Dong, N., Yang, M., Wang, J., Feng, X., & Wang, Y. (2021) · Journal of Immunology Research · doi:10.1155/2021/9945725 · Cited by 56
Age-related macular degeneration
Ayoub, T., & Patel, N. (2009) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2009.080298 · Cited by 59
Wu, K. H. C., Tan, A. G., Rochtchina, E., Favaloro, E. J., Williams, A., Mitchell, P., & Wang, J. J. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0223 · Cited by 57
Tanimoto, S., Tamura, H., Ue, T., Yamane, K., Maruyama, H., Kawakami, H., & Kiuchi, Y. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.011 · Cited by 55
ROLE OF GENETIC FACTORS AND INFLAMMATION IN AGE-RELATED MACULAR DEGENERATION
MOSHFEGHI, D. M., & BLUMENKRANZ, M. S. (2007) · Retina · doi:10.1097/iae.0b013e31802e3e9b · Cited by 52
New therapeutic targets in atrophic age-related macular degeneration
Petrukhin, K. E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.625 · Cited by 55
“Recent genetic studies established association between atrophic AMD and single nucleotide polymorphisms in complement factors H [64-67] and B [68], thus linking abnormal complement regulation with pathogenesis of AMD.”
BackgroundYang, H., Ratnapriya, R., Cogliati, T., Kim, J.-W., & Swaroop, A. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.01.005 · Cited by 55
Salomon, R. G., Hong, L., & Hollyfield, J. G. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200206v · Cited by 59
Fernández, A. B., Wong, T. Y., Klein, R., Collins, D. E., Burke, G. L., Cotch, M. F., Klein, B. E. K., Sadeghi, M. M., & Chen, J. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.09.044 · Cited by 57
“Both diseases are associated with atherosclerosis, (8) inflammation, (9, 10) complement activation (11) and a local up-regulation of vascular endothelial growth factor (VEGF).”
BackgroundWoodell, A., Coughlin, B., Kunchithapautham, K., Casey, S., Williamson, T., Ferrell, W. D., Atkinson, C., Jones, B. W., & Rohrer, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067894 · Cited by 52
Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration
Malek, G., & Lad, E. M. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1709-x · Cited by 55
Ristau, T., Paun, C., Ersoy, L., Hahn, M., Lechanteur, Y., Hoyng, C., de Jong, E. K., Daha, M. R., Kirchhof, B., den Hollander, A. I., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093459 · Cited by 52
Anti-complement activity of the Ixodes scapularis salivary protein Salp20
Hourcade, D. E., Akk, A. M., Mitchell, L. M., Zhou, H., Hauhart, R. E., & Pham, C. T. N. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.11.008 · Cited by 52
Bioinformatics Challenges in Genome-Wide Association Studies (GWAS)
De, R., Bush, W. S., & Moore, J. H. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0847-9_5 · Cited by 61
Haapasalo, K., Jarva, H., Siljander, T., Tewodros, W., Vuopio‐Varkila, J., & Jokiranta, T. S. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06347.x · Cited by 57
“…Y402H located within domain 7 has attracted great attention due to its strong association with age-related macular degeneration (AMD), the most frequent cause of visual loss in industrialized countries (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
BackgroundRapid inexpensive genome-wide association using pooled whole blood
Craig, J. E., Hewitt, A. W., McMellon, A. E., Henders, A. K., Ma, L., Wallace, L. M., Sharma, S., Burdon, K. P., Visscher, P. M., Montgomery, G. W., et al. (2009) · Genome Research · doi:10.1101/gr.094680.109 · Cited by 56
“…blood had been stored at 4°C for >12 mo. Previous studies of AMD have identified two major susceptibility loci; CFH (chromosome 1q32) and ARMS2/HTRA1 (chromosome 10q25-q26) (Edwards et al. 2005; Hageman et al. 2005; Klein et al. 2005; Dewan et al. 2006; Yang et al. 2006; Fritsche et al. 2008).”
BackgroundMurinello, S., Mullins, R. F., Lotery, A. J., Perry, V. H., & Teeling, J. L. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-11821 · Cited by 51
Richardson, A. J., Islam, A. F. M., Guymer, R. H., & Baird, P. N. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2423 · Cited by 57
Complement System and Potential Therapeutics in Age-Related Macular Degeneration
Park, Y. G., Park, Y. S., & Kim, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136851 · Cited by 53
“In 2005, several studies on genetic association proved that the CFH gene on chromosome 1q32 is the first gene associated with AMD risk [57,58].”
BackgroundPrevention of age-related macular degeneration
Wong, I. Y., Koo, S., & Chan, C. W. N. (2010) · International Ophthalmology · doi:10.1007/s10792-010-9397-5 · Cited by 62
Human retinal cadmium accumulation as a factor in the etiology of age-related macular degeneration
Wills, N. K., Kalariya, N. M., Ramanujam, V. M. S., Lewis, J. R., Abdollahi, S., Husain, A., & van Kuijk, F. J. G. M. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.02.014 · Cited by 51
“Multiple genes involved in immune responses also have been implicated, including mutations in the gene for complement factor H (Klein et al., 2005; Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Zareparsi et al., 2005), the genes PLEKHA1/LOC387715/HTRA1 (Rivera et al., 2005;…”
BackgroundCurrent and emerging therapies for the treatment of age-related macular degeneration
Lauer, A. K. (2008) · Clinical ophthalmology · doi:10.2147/opth.s1485 · Cited by 56
“One example of this is the recent association between complement factor H haplotypes and AMD (Edwards et al 2005).”
Sparing of age-related macular degeneration in rheumatoid arthritis
McGeer, P. L., & Sibley, J. T. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.02.003 · Cited by 54
Complement‐targeted therapeutics: Are we there yet, or just getting started?
Ricklin, D. (2024) · European Journal of Immunology · doi:10.1002/eji.202350816 · Cited by 54
Cheung, C. M. G., Bhargava, M., Laude, A., Koh, A. C., Xiang, L., Wong, D., Niang, T., Lim, T. H., Gopal, L., & Wong, T. Y. (2012) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2012.02765.x · Cited by 50
Liu, J., Jha, P., Lyzogubov, V. V., Tytarenko, R. G., Bora, N. S., & Bora, P. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.226266 · Cited by 49
Innate Immune Network in the Retina Activated by Optic Nerve Crush
Templeton, J. P., Freeman-Anderson, N. E., Nickerson, J. M., Jablonski, M. M., Rex, T. S., Williams, R. W., & Geisert, E. E. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11175 · Cited by 53
Resolution, the grail for healthy ocular inflammation
Gronert, K. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.07.004 · Cited by 55
“In human’s polymorphism in the complement system, namely complement factor H, (CFH), a major and obligatory circuit in the innate immune system of all organism has been identified as a risk factor for AMD (Edwards et al., 2005; Edwards and Malek, 2007; Raisler et al., 2008).”
BackgroundThe eye as a model of ageing in translational research – Molecular, epigenetic and clinical aspects
Pathai, S., Shiels, P. G., Lawn, S. D., Cook, C., & Gilbert, C. E. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.11.002 · Cited by 54
Role of Ocular Complement Factor H in a Murine Model of Choroidal Neovascularization
Lyzogubov, V. V., Tytarenko, R. G., Jha, P., Liu, J., Bora, N. S., & Bora, P. S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091168 · Cited by 51
Chakravarthy, U., McKay, G. J., de Jong, P. T. V. M., Rahu, M., Seland, J. H., Soubrane, G., Tomazzoli, L., Topouzis, F., Vingerling, J. R., Vioqué, J., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.08.004 · Cited by 52
Dual role of Nr2e3 in photoreceptor development and maintenance
Webber, A. L., Hodor, P. G., Thut, C. J., Vogt, T., Zhang, T., Holder, D., & Petrukhin, K. E. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.04.006 · Cited by 50
Presumed ocular histoplasmosis syndrome
Prasad, A. G., & Gelder, R. N. V. (2005) · Current Opinion in Ophthalmology · doi:10.1097/01.icu.0000188321.61101.93 · Cited by 50
Advances in the genomics of common eye diseases
Bailey, J. N. C., Sobrin, L., Pericak‐Vance, M. A., Haines, J. L., Hammond, C. J., & Wiggs, J. L. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt396 · Cited by 52
Chae, B., Jung, J. J., Mrejen, S., Gallego‐Pinazo, R., Yannuzzi, N. A., PATEL, S. N., Chen, C. Y., Marsiglia, M., Boddu, S., & Freund, K. B. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16494 · Cited by 53
“Polymorphism in the complement factor H gene and other genes responsible for the regulation of the complement pathway has been shown to be strongly associated with neovascular AMD.”
BackgroundInfluentialBora, N. S., Matta, B., Lyzogubov, V. V., & Bora, P. S. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.07.012 · Cited by 51
Kaur, I., Katta, S., Reddy, R. K., Narayanan, R., Mathai, A., Majji, A. B., & Chakrabarti, S. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4135 · Cited by 51
Shen, L., Frazer‐Abel, A. A., Reynolds, P. R., Giclas, P. C., Chappell, A. E., Pangburn, M. K., Younis, H. S., & Henry, S. P. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.219378 · Cited by 49
“…amino acid position 402) SNP in the human CFH has been shown to be highly correlated with increased risk of developing age-related macular degeneration as well as diseases in kidney, brain, and vascular tissues (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Donoso et al., 2010).”
BackgroundInfluentialLeveziel, N., Souied, E. H., Richard, F., Barbu, V., Zourdani, A., Morineau, G., Zerbib, J., COSCAS, G. J., Soubrane, G., & Benlian, P. (2007) · PubMed · Cited by 54
Risk Factors for Age-Related Maculopathy
Connell, P., Keane, P. A., O’Neill, E. C., Al‐Taie, R., Loane, E., Neelam, K., Nolan, J. M., & Beatty, S. (2009) · Journal of Ophthalmology · doi:10.1155/2009/360764 · Cited by 57
“Of these, the Y402H variant, which is located within a binding site for C-Reactive Protein (CRP), has the strongest association with ARM [64, 65, 215, 216].”
BackgroundFletcher, E. L. (2020) · Ophthalmic and Physiological Optics · doi:10.1111/opo.12671 · Cited by 54
“5 The importance of innate immunity in the development of AMD is exemplified by the accumulation of complement components within drusen deposits 6,7 and also the widespread inheritance of mutations in genes affecting the complement system including single nucleotide polymorphisms in Complement Factors H, B and I as wel…”
Cong, Q., Soteros, B. M., Huo, A., Li, Y., Tenner, A. J., & Sia, G. M. (2022) · Glia · doi:10.1002/glia.24114 · Cited by 49
“AMD is a leading cause of vision loss in the aged population in developed countries, and polymorphisms in complement factor H has been strongly associated with AMD risk (Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005).”
BackgroundLi, Y., Song, D., Song, Y., Zhao, L., Wolkow, N., Tobias, J. W., Song, W., & Dunaief, J. L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645903 · Cited by 51
Norris, J. M., Langefeld, C. D., Talbert, M. E., Wing, M. R., Haritunians, T., Fingerlin, T. E., Hanley, A. J. G., Ziegler, J. T., Taylor, K. D., Haffner, S. M., et al. (2009) · Obesity · doi:10.1038/oby.2009.143 · Cited by 48
“For example, the complement factor H gene association with macular degeneration, with 224 cases and 134 controls (23), NOS1AP gene association with cardiac repolarization with 200 subjects (24), TNFSF15 conferring susceptibility to Crohn’s disease with 94 subjects (25), and the recent report of association to coronary…”
BackgroundOkemefuna, A. I., Gilbert, H. E., Griggs, K. M., Ormsby, R. J., Gordon, D., & Perkins, S. J. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.09.026 · Cited by 49
Seitsonen, S. P., Järvelä, I. E., Meri, S., Tommila, P. V., Ranta, P. H., & Immonen, I. J. (2007) · European Journal of Ophthalmology · doi:10.1177/112067210701700612 · Cited by 48
Halawa, O. A., Lin, J. B., Miller, J. W., & Vavvas, D. G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122580 · Cited by 48
Landowski, M., & Rickman, C. B. (2022) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2021.0067 · Cited by 48
de Córdoba, S. R. (2022) · Immunological Reviews · doi:10.1111/imr.13131 · Cited by 56
Saeed, M., Beggs, M. L., Walker, P. D., & Larsen, C. P. (2014) · Genes and Immunity · doi:10.1038/gene.2014.50 · Cited by 52
Fan, Q., Cheung, C. M. G., Chen, L. J., Yamashiro, K., Ahn, J., Laude, A., Mathur, R., Chan, C. M., Yeo, I. Y. S., Lim, T. H., et al. (2017) · Journal of Human Genetics · doi:10.1038/jhg.2017.83 · Cited by 49
Pinna, A., Porcu, T., Ricci, G. D., Dore, S. E., Boscia, F., Paliogiannis, P., Carru, C., & Zinellu, A. (2018) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2018.1485960 · Cited by 53
Kezic, J., Xu, H., Chinnery, H. R., Murphy, C. C., & McMenamin, P. G. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0953 · Cited by 48
Friedrich, U., Stöhr, H., Hilfinger, D., Loenhardt, T., Schachner, M., Langmann, T., & Weber, B. H. F. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq557 · Cited by 53
Montes, T., Goicoechea de Jorge, E., Ramos, R., Gomà, M., Pujol, O., Sánchez-Corral, P., & Rodríguez de Córdoba, S. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.01.027 · Cited by 47
Khandhadia, S., Hakobyan, S., Heng, L. Z., Gibson, J., Adams, D. H., Alexander, G. J., Gibson, J. M., Martin, K. R., Menon, G., Nash, K., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.01.004 · Cited by 47
Cherepanoff, S., Mitchell, P., Wang, J. J., & Gillies, M. C. (2006) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2006.01281.x · Cited by 47
Pan, Y., Fu, Y., Baird, P. N., Guymer, R. H., Das, T., & Iwata, T. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101159 · Cited by 50
Aberrant Lipid Metabolism and Complement Activation in Age-Related Macular Degeneration
Tang, S., Yang, J., Xiao, B., Wang, Y., Lei, Y., Lai, D., & Qiu, Q. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.12.20 · Cited by 49
“46 Notably, individuals homozygous for the risk allele have a 7.4-fold increased likelihood of developing AMD (95% confidence interval, 2.9 to 19).”
BackgroundInfluentialRyu, E., Fridley, B. L., Tosakulwong, N., Bailey, K. R., & Edwards, A. O. (2010) · PubMed Central · Cited by 53
Self-citationNaj, A. C., Scott, W. K., Courtenay, M. D., Cade, W. H., Schwartz, S. G., Kovach, J. L., Agarwal, A., Wang, G., Haines, J. L., & Pericak‐Vance, M. A. (2013) · Annals of Human Genetics · doi:10.1111/ahg.12011 · Cited by 49
“Among nonmodifiable risk factors for AMD, several genes have been identified through linkage and association studies, among which the most replicated are CFH (encoding complement factor H) (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005), CFB/C2 (encoding complement factor B and co…”
BackgroundSchmid‐Kubista, K. E., Tosakulwong, N., Wu, Y., Ryu, E., Hecker, L. A., Baratz, K. H., Brown, W. L., & Edwards, A. O. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3975 · Cited by 51
Self-citationSteinberg, J. S., Auge, J. A. I., Jaffe, G. J., Fleckenstein, M., Holz, F. G., & Schmitz-Valckenberg, S. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11538 · Cited by 51
How to overcome retinal neuropathy: The fight against angiogenesisrelated blindness
Jo, D. H., Kim, J. H., & Kim, J. H. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-1007-6 · Cited by 49
“In AMD, activation of the complement system seems to be associated with the integrity of RPE cells (Thurman et al., 2009), and this conclusion has come from genetic studies of patients with AMD which showed mutations in the complement factor H gene (Edwards et al., 2005).”
Hu, H., Liu, Y., Wang, L., & Li, W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173716 · Cited by 48
Population-Based Study of Early Age-Related Macular Degeneration
Tedeschi‐Blok, N., Buckley, J. D., Varma, R., Triche, T. J., & Hinton, D. R. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.07.043 · Cited by 47
Metadata
- Authors
- Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A.
- Affiliations
- Boston University (US)
- Corresponding author
- Edwards, Albert O.
- Venue
- Science
- Published
- 2005-04-15
- Volume
- 308
- Issue
- 5720
- Pages
- 421-424
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3145351529
- Cited by
- 2,449
- References
- 30
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 51 · 2023: 48 · 2022: 78 · 2021: 105 · 2020: 73 · 2019: 52 · 2018: 81 · 2017: 65 · 2016: 89 · 2015: 120 · 2014: 141 · 2013: 146 · 2012: 166
- FWCI
- 195.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (EY014467, R01EY014467)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, complement factor H, CFH Y402H polymorphism, single nucleotide polymorphisms, genetic association, disease risk
- MeSH terms
- Aged, Alleles, Chromosomes, Human, Pair 1, Complement Activation, Female, Gene Frequency, Multigene Family, Genotype, Haplotypes, Histidine, Homozygote, Humans, Macular Degeneration, Male, Middle Aged, Risk Factors, Tyrosine, Genetic Variation, Linkage Disequilibrium, Case-Control Studies, Complement Factor H, Amino Acid Substitution, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.